...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: THIS IS NEW ,,, What if

PVLee's post on Dec 12 , 2015 What if ? Is worth a reread ...

I believe this has been Don's plan all along (since they decided not to sell outright to Big Pharma) I believe Company, Resverlogix realized what they had and when going into phase 111 alone solidified their belief . This plan was to ensure longtime investors benifited the most. Don has touted this for along time ...Dividends dividends dividends, indicates multiple (newco spinoffs) for the many different dieseases our combined scoffold of potential molecules contains ! Hats off to you PVLee ,,, I see things developing much the same way you do !

Just my two pennies !

Stock

4
Jan 15, 2016 11:36AM
3
Jan 18, 2016 04:00PM
Share
New Message
Please login to post a reply